Are the new ‘diabetes’ medicine really cardiology drugs?

Back

ESC Premium Access

Are the new ‘diabetes’ medicine really cardiology drugs?

Session: Impact of novel guidelines: transforming diabetes management in cardiology

Topic: Risk Factors and Prevention

Speaker: Professor J. Deanfield (London, GB) Professor N. Marx (Aachen, DE)

Organised by PACE-CME, supported with an educational grant provided by Novo Nordisk

Event: ESC Congress 2019

Congress Presentation

Add to my library

About the speakers

Professor John Eric Deanfield

University College London, London (United Kingdom of Great Britain & Northern Ireland)

53 presentations

3 followers

Professor Nikolaus Marx

RWTH University Hospital Aachen, Aachen (Germany)

52 presentations

13 followers

3 more presentations in this session

Guidelines on diabetes, pre-diabetes and cardiovascular diseases in a nutshell

Speaker: Professor F. Cosentino (Stockholm, SE)

Access

Slides

Video

The diabetes challenge for cardiologists

Speaker: Professor F. Krag Knop (Copenhagen, DK)

Access

Challenge the experts: panel and audience discussion

Speaker: Professor F. Krag Knop (Copenhagen, DK) Professor J. Deanfield (London, GB) Professor F. Cosentino (Stockholm, SE) Professor N. Marx (Aachen, DE)

Access

Access the full session

Impact of novel guidelines: transforming diabetes management in cardiology

Speakers: Professor J. Deanfield, Professor N. Marx, Professor F. Cosentino, Professor F. Krag Knop, Professor F. Krag Knop...

Access

About the event

ESC Congress 2019

31 August - 4 September 2019

Sessions Presentations

Congress

ESC 365 is supported by

Explore sponsored resources